Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1500350	恩格列净片	empagliflozin	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-06-29	方正医药研究院有限公司	Pkucare Pharmaceutical R&D Center	Certificate Issued	2016-08-12	view
CXHL1500349	恩格列净	empagliflozin	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2015-06-29	方正医药研究院有限公司	Pkucare Pharmaceutical R&D Center	Certificate Issued	2016-08-12	view
CXHL1500352	恩格列净片	empagliflozin	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-06-29	方正医药研究院有限公司	Pkucare Pharmaceutical R&D Center	Certificate Issued	2016-08-12	view
CXHL1402235	FZ016	FZ016	Active ingredient	Chemical Drugs(1.1)	New Drug Application	2015-05-08	方正医药研究院有限公司	Pkucare Pharmaceutical R&D Center	Certificate Issued	2016-08-12	view
CXHL1402236	FZ016胶囊	FZ016	Capsule	Chemical Drugs(1.1)	New Drug Application	2015-05-08	方正医药研究院有限公司	Pkucare Pharmaceutical R&D Center	Certificate Issued	2016-08-12	view
CXHL1200056	丙戊酸半钠缓释片	divalproex sodium	Tablet, extended release	Chemical Drugs(3.1)	New Drug Application	2012-05-08	方正医药研究院有限公司	Pkucare Pharmaceutical R&D Center	Certificate Issued	2015-08-11	view
CXHL1200055	丙戊酸半钠	divalproex sodium	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2012-05-08	方正医药研究院有限公司	Pkucare Pharmaceutical R&D Center	Certificate Issued	2015-08-11	view